Rilogrotug clinical trials
Also written AV-380.
How each study uses rilogrotug is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the rilogrotug studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2021 (1)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses rilogrotug is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLCNot yet recruitingPhase 2/3AVEO Pharmaceuticals, Inc.NCT07888075Written as Rilogrotug
- A Dose Escalation Study of AV-380 in Cancer Patients With CachexiaCompletedPhase 1AVEO Pharmaceuticals, Inc.NCT05865535Written as AV-380
- A Phase 1 Study of AV-380 in Healthy SubjectsCompletedPhase 1AVEO Pharmaceuticals, Inc.NCT04815551Written as AV-380
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered1
Codes
What other systems call rilogrotug · ClinicalTrials.gg INT017186
- UNII (FDA) LI86LS4ZURRILOGROTUGOne source FDA
- NCI Thesaurus C200801RilogrotugOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | LI86LS4ZUR | RILOGROTUG | One source FDA |
| NCI Thesaurus | C200801 | Rilogrotug | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.